Thyrocare Technologies Limited (“Thyrocare”) (NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company in India, has appointed Rajdeep Panwar as its Chief Commercial Officer (CCO). With this appointment, Thyrocare aims to further sharpen its commercial strategy and strengthen customer engagement nationwide.
Experienced Leader Joins Thyrocare’s Growth Journey
Rajdeep Panwar brings a strong techno-commercial background and extensive leadership experience in the healthcare and diagnostics sector. Notably, he has led P&L operations, driven multi-market expansions, and scaled large, multi-centre diagnostic businesses across India.
Over the years, Rajdeep has played a key role in launching and managing more than 200 diagnostic laboratories. In addition, he has been a founding team member of two healthcare ventures, demonstrating his ability to build and scale businesses from the ground up.
Proven Track Record Across Leading Healthcare Brands
Prior to joining Thyrocare, Rajdeep served as Director at GHL Pharma & Diagnostics Ltd. (GHL–Medanta). During his tenure, he successfully expanded Medanta Labs across North India. Furthermore, his career includes leadership roles at prominent organisations such as Apollo Diagnostics, Johnson & Johnson, and Dr. Lal PathLabs.
Across these roles, he led initiatives spanning business expansion, commercial strategy, technical operations, customer support, process excellence, accreditation, and organisational transformation. As per a press release, this diverse experience positions him well to lead Thyrocare’s next phase of growth.
Rajdeep Panwar on Joining Thyrocare
Commenting on his appointment, Rajdeep Panwar said,
“I am excited to join Thyrocare at a pivotal phase of its growth. The company’s mission to make high-quality diagnostics affordable and accessible across India strongly resonates with me. With its deep partner network and strong scientific foundation, Thyrocare is well positioned to get closer to patients and drive meaningful impact at scale.”
Leadership Perspective from API Holdings
Rahul Guha, Managing Director and CEO of API Holdings, emphasised the importance of the appointment, stating,
“As Thyrocare continues to scale, strengthening our leadership team is critical, particularly in commercial leadership. Rajdeep brings deep experience in building and expanding diagnostics businesses in India. We believe his leadership will help strengthen our market approach and deepen engagement with customers and partners.”
He further added that, alongside Dr. Kinha, who recently joined as Chief Operating Officer (COO) and brings strong operational and quality expertise, Thyrocare’s leadership team is now well positioned to succeed in a rapidly growing market.
Role and Responsibilities as Chief Commercial Officer
In his new role, Rajdeep Panwar will oversee Thyrocare’s end-to-end commercial functions, including franchise and corporate businesses, direct-to-consumer channels, customer relationship management, customer operations, catalogue management, and radiology services. Additionally, he will take full responsibility for the company’s P&L.
Through this role, he will focus on driving revenue growth, enhancing customer experience, and expanding Thyrocare’s footprint across India.